Oxidation of 5-Hydroxymethylfurfural into 2,5-Diformylfuran on Alkali Doped Ru/C Catalysts. Electron Properties of Ruthenium Species as Descriptor of Catalytic Activity.

Selective aerobic oxidation of 5-hydroxymethylfurfural into 2,5-diformylfuran has been achieved on alkali doped Ru/C catalyst. Optimization of Ru metal nanoparticles, as well as the nature and amount of the alkali dopant have been performed. The results showed that doping the Ru/C catalyst with controlled amount of potassium increases the catalytic activity, 2.

Stabilization of the Active Ruthenium Oxycarbonate Phase for Low-Temperature CO Methanation.

Interstitial carbon-doped RuO catalyst with the newly reported ruthenium oxycarbonate phase is a key component for low-temperature CO methanation. However, a crucial factor is the stability of interstitial carbon atoms, which can cause catalyst deactivation when removed during the reaction. In this work, the stabilization mechanism of the ruthenium oxycarbonate active phase under reaction conditions is studied by combining advanced operando spectroscopic tools with catalytic studies.

Water and Cu Synergy in Selective CO Hydrogenation to Methanol over Cu-MgO-AlO Catalysts.

The CO hydrogenation reaction to produce methanol holds great significance as it contributes to achieving a CO-neutral economy. Previous research identified isolated Cu species doping the oxide surface of a Cu-MgO-AlO-mixed oxide derived from a hydrotalcite precursor as the active site in CO hydrogenation, stabilizing monodentate formate species as a crucial intermediate in methanol synthesis. In this work, we present a molecular-level understanding of how surface water and hydroxyl groups play a crucial role in facilitating spontaneous CO activation at Cu sites and the formation of monodentate formate species.

Measuring health-related quality of life in sarcopenia: summary of the SarQoL psychometric properties.

Patient perspectives are now widely recognized as a key element in the evaluation of health interventions. Therefore, the provision of specific and validated Patient Reported Outcome Measures that emphasize the lived experience of patients suffering from specific diseases is very important. In the field of sarcopenia, the only validated specific health-related quality of life (HRQoL) instrument available is the Sarcopenia Quality of Life questionnaire (SarQoL).